Form 4 Filing: Feider Stephen Sells $84,165 of $BBNX
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Feider Stephen, holds the title of Chief Financial Officer at Beta Bionics, Inc..
On 2026-06-02, the insider transacted 6,676 shares.The shares were transacted at a weighted average price of $12.61 per share, resulting in a total market-relevant value of $84,165.
**Transaction:** sell of 6,676 shares by Feider Stephen (Chief Financial Officer). **Strategic Implications (Investor Edge):** The sale is small relative to the CFO's total stake and lacks context of a 10b5-1 plan, but the modest size and retained large position indicate no urgent bearish signal. Investors should monitor for any subsequent filings or company announcements to assess if this is part of a broader pattern. **Key Takeaways:** - CFO sold a small fraction (3.9%) of his holdings, retaining 166,053 shares. - Transaction value of $84,165 is not material for a C-suite executive. - No open market purchase or large liquidation; trade appears routine or tax-related.
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.